Cisen Pharmaceutical Co., Ltd.

SSE:603367.SS

14.89 (CNY) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32015 Q22015 Q1
Revenue 920.204979.322931.726910.191,148.9471,252.491990.1481,085.3071,134.4031,154.2531,048.37993.695869.7711,025.427925.612957.848873.7061,023.735992.242835.521822.661,116.2231,040.229963.795992.5381,016.55919.756924.161947.611998.31715.516701.764546.926855.402513.557583.378583.378
Cost of Revenue 370.718443.858410.373473.794434.45460.335388.424569.318420.947523.282425.847447.192392.971501.767411.92416.575354.384494.619409.374326.393340.515457.975453.675405.383433.649455.509371.839373.506420.889437.916338.434390.416282.464507.535278.603376.716376.716
Gross Profit 549.486535.464521.353436.395714.496792.155601.724515.988713.456630.971622.523546.502476.799523.66513.692541.272519.322529.117582.868509.128482.145658.248586.555558.413558.888561.042547.917550.655526.722560.394377.082311.348264.462347.867234.954206.662206.662
Gross Profit Ratio 0.5970.5470.560.4790.6220.6320.6080.4750.6290.5470.5940.550.5480.5110.5550.5650.5940.5170.5870.6090.5860.590.5640.5790.5630.5520.5960.5960.5560.5610.5270.4440.4840.4070.4580.3540.354
Reseach & Development Expenses 73.64470.33593.21767.455100.074119.466100.02663.6291.77193.29391.48885.47164.91787.93788.54788.24969.61485.15358.0198.36168.0698.74346.80556.721108.29154.07175.71149.53446.666160.1449.09874.7620108.692020.74120.741
General & Administrative Expenses 63.298-124.747178.52-31.20376.351-106.704163.531-29.08270.338-99.366151.553-29.59862.574-74.62117.621-14.341.077-75.03348.965-16.01741.365-69.34944.687-10.39444.01-52.35741.772-41.55471.445-207.645113.376-22.11346.898-161.84363.23245.73945.739
Selling & Marketing Expenses 227.815220.752246.593258.831340.417387.994293.868278.03374.768404.619346.791315.673238.885324.88306.492317.629297.878291.921317.052331.118243.89422.223310.499295.87274.762204.298278.436304.209302.499335.459163.905122.512138.935187.39983.08578.7178.71
SG&A 291.11396.005425.113295.616416.768281.29457.399248.948445.106305.253498.344286.074301.459250.26424.113303.33338.954216.888366.016315.101285.255352.874355.186285.475318.772151.941320.208262.655373.944127.814277.281100.399185.83325.556146.317129.305129.305
Other Expenses 24.37232.89-142.671-7.4521.2182.5830.404-0.06412.457168.616-73.51491.0426.4850.9470.6380.648-0.5220.454-1.5661.108-0.153-4.3771.1511.1551.4670.5811.672-0.3770.492-9.294.57910.4510.6184.5396.1500
Operating Expenses 389.127399.23375.659370.523510.918584.01475.066406.489549.334567.161516.318462.587372.862485.405455.875455.979414.273420.381434.835467.221354.891579.533409.973393.849439.481419.206405.075405.733384.707357.472288.026238.427188.487252.918151.954135.543135.543
Operating Income 160.359136.235145.69365.873182.477171.166130.983119.479170.9567.206107.01886.76103.59833.313104.86176.52119.727122.235167.12676.705118.607104.542191.608142.893143.673136.536160.261124.521144.293188.286.40375.64365.96190.10483.09669.26669.266
Operating Income Ratio 0.1740.1390.1560.0720.1590.1370.1320.110.1510.0580.1020.0870.1190.0320.1130.080.1370.1190.1680.0920.1440.0940.1840.1480.1450.1340.1740.1350.1520.1890.1210.1080.1210.1050.1620.1190.119
Total Other Income Expenses Net -0.3370.5961.1860.7261.2182.5830.404-0.0640.356-2.7181.170.6532.5030.9470.63827.724-0.522-0.562-1.6931.108-0.153-4.3771.1511.1551.4670.5811.672-0.3770.4921.4153.5710.7550.6183.6596.150.1710.171
Income Before Tax 160.022136.831146.879108.368183.695173.749131.386119.415171.30664.488108.18987.413106.10234.26105.49977.168119.205122.69165.5677.812118.455100.164192.759144.048145.14137.118161.933124.143144.784178.91790.97786.09166.57994.42389.24769.43769.437
Income Before Tax Ratio 0.1740.140.1580.1190.160.1390.1330.110.1510.0560.1030.0880.1220.0330.1140.0810.1360.120.1670.0930.1440.090.1850.1490.1460.1350.1760.1340.1530.1790.1270.1230.1220.110.1740.1190.119
Income Tax Expense 15.4125.24317.243-3.16621.51343.9082.6899.73314.1-0.985.0290.2739.484-14.2852.7413.20710.5669.59819.6115.44312.503-3.0534.21118.75117.4059.16721.2879.51224.95815.715.60810.15815.4211.41614.84411.69411.694
Net Income 143.545110.787127.802107.454162.863130.892126.295108.302155.8557.743108.2887.30296.74848.645102.80574.006108.69113.109146.00973.674105.992103.126158.543125.271127.641127.902140.511115.232119.899163.12376.36776.49551.23782.77174.72658.13158.131
Net Income Ratio 0.1560.1130.1370.1180.1420.1050.1280.10.1370.050.1030.0880.1110.0470.1110.0770.1240.110.1470.0880.1290.0920.1520.130.1290.1260.1530.1250.1270.1630.1070.1090.0940.0970.1460.10.1
EPS 0.320.2450.280.240.360.290.280.240.350.130.240.190.220.110.230.160.240.250.320.160.230.230.350.270.280.280.310.250.260.470.210.210.140.230.210.170.17
EPS Diluted 0.320.2450.280.240.360.290.280.240.350.130.240.190.210.110.230.160.240.250.320.160.230.230.350.270.280.280.310.250.260.470.210.210.140.230.210.170.17
EBITDA 160.254138.092149.875168.739244.073247.533204.891167.469218.262124.35167.219144.769169.74111.713143.424130.474175.083163.076206.842121.948161.634153.108243.16164.564176.759138.201142.842155.449148.052185.948105.95576.73481.07282.1528380.68980.689
EBITDA Ratio 0.1740.1410.1610.1850.2120.1980.2070.1540.1920.1080.160.1460.1950.1090.1550.1360.20.1590.2080.1460.1960.1370.2340.1710.1780.1360.1550.1680.1560.1860.1480.1090.1480.0960.1620.1380.138